Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2536 AL 2550

A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials

Gonzales MM, Krishnamurthy S, Garbarino V, Daeihagh AS, Gillispie GJ, Deep G, Craft S, Orr ME.

Mech Ageing Dev. 2021 Dec;200:111589. doi: 10.1016/j.mad.2021.111589. Epub 2021 Oct 21.

FDA Drug Approval and the Ethics of Desperation

Largent EA, Peterson A, Lynch HF.

JAMA Intern Med. 2021 Dec 1;181(12):1555-1556. doi: 10.1001/jamainternmed.2021.6045.

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease

Kandadi Muralidharan K, Tong X, Kowalski KG, Rajagovindan R, Lin L, Budd Haberlain S, Nestorov I.

CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):7-19. doi: 10.1002/psp4.12728. Epub 2021 Oct 26.

A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease

Arora S, Sharma D, Layek B, Singh J.

Mol Pharm. 2021 Dec 6;18(12):4237-4255. doi: 10.1021/acs.molpharmaceut.1c00611. Epub 2021 Oct 27.

Nanomaterials in Alzheimer's disease treatment: a comprehensive review

Faiyaz M, Ganayee MA, Akhtar S, Krishnan S, Flora B, Dogra D, Jha NK, Chellappan DK, Negi P, Dua K, Kesari KK, Gupta PK.

Front Biosci (Landmark Ed). 2021 Oct 30;26(10):851-865. doi: 10.52586/4992.

Artificial Chiral Interfaces against Amyloid-β Peptide Aggregation: Research Progress and Challenges

Zhou Z, Gu YQ, Wang HX.

ACS Chem Neurosci. 2021 Nov 17;12(22):4236-4248. doi: 10.1021/acschemneuro.1c00544. Epub 2021 Nov 1.

Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease

Dhapola R, Sarma P, Medhi B, Prakash A, Reddy DH.

Mol Neurobiol. 2022 Jan;59(1):535-555. doi: 10.1007/s12035-021-02612-6. Epub 2021 Nov 2.

Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease

Zhou XB, Zhang YX, Zhou CX, Ma JJ.

Chin J Integr Med. 2022 Feb;28(2):176-184. doi: 10.1007/s11655-021-3342-5. Epub 2021 Nov 3.

Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review

Haghighijoo Z, Zamani L, Moosavi F, Emami S.

Eur J Med Chem. 2022 Jan 5;227:113949. doi: 10.1016/j.ejmech.2021.113949. Epub 2021 Oct 27.

The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives

Walgrave H, Zhou L, De Strooper B, Salta E.

Mol Neurodegener. 2021 Nov 6;16(1):76. doi: 10.1186/s13024-021-00496-7.

Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion

Matthiesen ST, Rosenkjær S, Pontén M, Jensen KB, Gottrup H, Vase L.

J Alzheimers Dis. 2021;84(4):1821-1832. doi: 10.3233/JAD-210108.

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia V, Kaushik D, Mittal V, Kumar K, Verma R, Parashar J, Akter R, Rahman MH, Bhatia S, Al-Harrasi A, Karthika C, Bhattacharya T, Chopra H, Ashraf GM.

Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9.

Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial

Wu X, Ji GJ, Geng Z, Wang L, Yan Y, Wu Y, Xiao G, Gao L, Wei Q, Zhou S, Wei L, Tian Y, Wang K.

Brain Stimul. 2022 Jan-Feb;15(1):35-45. doi: 10.1016/j.brs.2021.11.007. Epub 2021 Nov 6.

An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia

Dutta S, Rahman S, Ahmad R, Kumar T, Dutta G, Banerjee S, Abubakar AR, Rowaiye AB, Dhingra S, Ravichandiran V, Kumar S, Sharma P, Haque M, Charan J.

Expert Rev Neurother. 2021 Dec;21(12):1455-1472. doi: 10.1080/14737175.2021.2003705. Epub 2021 Nov 29.

An alarm on vitamin D therapy for Alzheimer's disease patients: a case with Alzheimer's disease whose symptoms were exacerbated under chronic use of eldecalcitol

Nakajima-Ohyama KC, Tansho K, Tanimukai H.

Psychogeriatrics. 2022 Jan;22(1):145-148. doi: 10.1111/psyg.12786. Epub 2021 Nov 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias